Yayi Jiang

Yayi Jiang

Auto-generated profile, based on publicly available information

Yayi Jiang

Hospital of Chengdu University of Traditional Chinese Medicine, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ZHZhipeng Hu
Zhipeng Hu
YLYuan Li
Yuan Li
LZLili Zhang
Lili Zhang
YJYayi Jiang
Yayi Jiang
CLCaiyi Long
Caiyi Long
MYMaoyi Yang
Maoyi Yang
Fibroblast-like synoviocytes (FLS) are important components of the synovial membrane. They can contribute to joint damage through crosstalk with inflammatory cells and direct actions on tissue damage pathways in rheumatoid arthritis (RA). Recent evidence suggests that, compared with FLS in normal synovial tissue, FLS in RA synovial tissue exhibits significant differences in metabolism. Recent metabolomic studies have demonstrated that metabolic changes, including those in glucose, lipid, and amino acid metabolism, exist before synovitis onset. These changes may be a result of increased biosynthesis and energy requirements during the early phases of the disease. Activated T cells and some cytokines contribute to the conversion of FLS into cells with metabolic abnormalities and pro-inflammatory phenotypes. This conversion may be one of the potential mechanisms behind altered FLS metabolism. Targeting metabolism can inhibit FLS proliferation, providing relief to patients with RA. In this review, we aimed to summarize the evidence of metabolic changes in FLS in RA, analyze the mechanisms of these metabolic alterations, and assess their effect on RA phenotype. Finally, we aimed to summarize the advances and challenges faced in targeting FLS metabolism as a promising therapeutic strategy for RA in the future.

15 November 2023 in Food & Function
Verified
Journal Article
Closed access
PDF file
YJYayi Jiang
Yayi Jiang
ZLZihan Li
Zihan Li
RYRensong Yue
Rensong Yue
GLGuojie Liu
Guojie Liu
MYMaoyi Yang
Maoyi Yang
DYDawei Yan
Dawei Yan
Garlic (Allium sativum L.) is a popular spice that is widely used for food and medicinal purposes and has shown potential effects on diabetic kidney disease (DKD). Nevertheless, systematic preclinical studies are still lacking. In this meta-analysis and systematic review, we evaluated the role and potential mechanisms of action of garlic and its derived components in animal models of DKD. We searched eight databases for relevant studies from the establishment of the databases to December 2022 and updated in April 2023 before the completion of this review. A total of 24 trials were included in the meta-analysis. It provided preliminary evidence that supplementing with garlic could improve the indicators of renal function (BUN, Scr, 24 h urine volume, proteinuria, and KI) and metabolic disorders (BG, insulin, and body weight). Meanwhile, the beneficial effects of garlic and its components in DKD could be related to alleviating oxidative stress, suppressing inflammatory reactions, delaying renal fibrosis, and improving glucose metabolism. Furthermore, time–dose interval analysis exhibited relatively greater effectiveness when garlic products were supplied at doses of 500 mg kg−1 with interventions lasting 8–10 weeks, and garlic components were administered at doses of 45–150 mg kg−1 with interventions lasting 4–10 weeks. This meta-analysis and systematic review highlights for the first time the therapeutic potential of garlic supplementation in animal models of DKD and offers a more thorough evaluation of its effects and mechanisms to establish an evidence-based basis for designing future clinical trials.